These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3811318)

  • 1. Generation and degradation of fibrinopeptide A in stored platelet concentrate.
    Bode AP; Miller DT
    Vox Sang; 1986; 51(3):192-6. PubMed ID: 3811318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
    Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
    J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of fibrinopeptide A in human blood.
    Nossel HL; Yudelman I; Canfield RE; Butler VP; Spanondis K; Wilner GD; Qureshi GD
    J Clin Invest; 1974 Jul; 54(1):43-53. PubMed ID: 4600045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic activity during storage of platelets in plasma.
    Wallvik J; Suontaka AM; Blombäck M
    Transfus Med; 1992 Jun; 2(2):135-42. PubMed ID: 1308210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation.
    Kaplan KL; Nossel HL; Drillings M; Lesznik G
    Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinopeptide A during normal pregnancy.
    Romero R; Rickles FR; Matthews E; Scott D; Dinan C; Duffy T
    Am J Perinatol; 1988 Jan; 5(1):70-3. PubMed ID: 3257391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of thrombin-antithrombin complex (TAT) levels and fibrinopeptide A following thrombin incubation of human plasma using hirudin as an inhibitor of TAT formation.
    Haaland AK; Skjønsberg OH; Gravem K; Ruyter R; Godal HC
    Thromb Res; 1991 Feb; 61(3):253-9. PubMed ID: 2028444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15-42.
    Hamaguchi M; Bunce LA; Sporn LA; Francis CW
    Blood; 1993 May; 81(9):2348-56. PubMed ID: 8481515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T
    Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPACK-thrombin inhibits thrombin-induced platelet aggregation and cytoplasmic acidification but does not inhibit platelet shape change.
    Greco NJ; Tenner TE; Tandon NN; Jamieson GA
    Blood; 1990 May; 75(10):1989-90. PubMed ID: 2337670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of direct and antithrombin-dependent thrombin inhibitors on the procoagulant and anticoagulant effects of thrombin.
    Linder R; Frebelius S; Grip L; Swedenborg J
    Thromb Res; 2003 Jun; 110(4):221-6. PubMed ID: 14512086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
    Weitz JI; Leslie B; Hudoba M
    Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of in vitro function of platelets stored in the presence of inhibitors of platelet activation and a specific inhibitor of thrombin.
    Bode AP; Miller DT
    J Lab Clin Med; 1988 Jan; 111(1):118-24. PubMed ID: 3335821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of activation of prothrombin by streptokinase compared with urokinase and tissue-type plasminogen activator (t-PA).
    Eisenberg PR; Miletich JP; Sobel BE; Jaffe AS
    Thromb Res; 1988 Jun; 50(5):707-17. PubMed ID: 3137687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a commercial kit for the radioimmunoassay of fibrinopeptide A.
    Butt RW; deBoer AC; Turpie AG
    J Immunoassay; 1984; 5(3-4):245-66. PubMed ID: 6530485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.
    Eisenberg PR; Lucore C; Kaufman L; Sobel BE; Jaffe AS; Rich S
    Circulation; 1990 Sep; 82(3):841-7. PubMed ID: 2394005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombin formation in factor IX concentrates and FEIBA (factor eight inhibitor bypassing activity) (proceedings)].
    Hofmann V; Ermanni M; Straub PW
    Schweiz Med Wochenschr; 1978 Oct; 108(41):1600. PubMed ID: 694497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.